Review




Structured Review

Biofluids Inc mirna from biofluids
Bioinformatic analysis of key biofluid-derived microRNAs. Top enriched pathways (Fisher exact test p < 0.05) associated with ( a ) most consistent <t>miRNA</t> <t>across</t> <t>biofluids,</t> miR-331-5p ( b ) most reported miRNA, miR-24-3p and miR-214-3p and ( c ) miRNA reported without conflicting direction of change, miR-19b-3p, miR-24-3p, miR-146a-5p, and miR-221-3p and ( d ) Venn Diagram showing the target genes regulated by the key biofluid-derived microRNAs. Overlapping target genes: CCND2 (Cyclin D2), CDK6 (Cyclin Dependent Kinase 6), CDNKN1A (cyclin dependent kinase inhibitor 1A) and MDM2 (Mouse Double Minute 2).
Mirna From Biofluids, supplied by Biofluids Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirnas+from+biofluids/mirnas+in+biofluids/pmc10539377-52-8-10
Average 90 stars, based on 1 article reviews
mirna from biofluids - by Bioz Stars, 2026-09
90/100 stars

Images

1) Product Images from "MicroRNAs in Parkinson’s disease: a systematic review and diagnostic accuracy meta-analysis"

Article Title: MicroRNAs in Parkinson’s disease: a systematic review and diagnostic accuracy meta-analysis

Journal: Scientific Reports

doi: 10.1038/s41598-023-43096-9

Bioinformatic analysis of key biofluid-derived microRNAs. Top enriched pathways (Fisher exact test p < 0.05) associated with ( a ) most consistent miRNA across biofluids, miR-331-5p ( b ) most reported miRNA, miR-24-3p and miR-214-3p and ( c ) miRNA reported without conflicting direction of change, miR-19b-3p, miR-24-3p, miR-146a-5p, and miR-221-3p and ( d ) Venn Diagram showing the target genes regulated by the key biofluid-derived microRNAs. Overlapping target genes: CCND2 (Cyclin D2), CDK6 (Cyclin Dependent Kinase 6), CDNKN1A (cyclin dependent kinase inhibitor 1A) and MDM2 (Mouse Double Minute 2).
Figure Legend Snippet: Bioinformatic analysis of key biofluid-derived microRNAs. Top enriched pathways (Fisher exact test p < 0.05) associated with ( a ) most consistent miRNA across biofluids, miR-331-5p ( b ) most reported miRNA, miR-24-3p and miR-214-3p and ( c ) miRNA reported without conflicting direction of change, miR-19b-3p, miR-24-3p, miR-146a-5p, and miR-221-3p and ( d ) Venn Diagram showing the target genes regulated by the key biofluid-derived microRNAs. Overlapping target genes: CCND2 (Cyclin D2), CDK6 (Cyclin Dependent Kinase 6), CDNKN1A (cyclin dependent kinase inhibitor 1A) and MDM2 (Mouse Double Minute 2).

Techniques Used: Derivative Assay

Related Articles

Isolation:

Article Title: MicroRNAs in biofluids are novel tools for bladder cancer screening
Article Snippet: Currently, there are many methodological pitfalls that need to be addressed in order for miRNAs from biofluids to be used for clinical applications.

Article Title: Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age
Article Snippet: Given the robust stability of miRNAs in plasma, circulating miRNAs have been used as excellent potential biomarkers for complex systemic diseases, and many studies have shown that miRNAs from biofluids can be used as risk markers for cardiovascular complications [11,15].

Article Title: Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera.
Article Snippet: MicroRNAs (miRNAs) are small non-coding RNA sequences that regulate gene expression post-transcriptionally by translation inhibition or mRNA degradation.. The aim of the present study was to analyze serum miRNAs modulated by hyperlipidemia and/or hyperglycemia and to correlate them with biochemical parameters within lipid metabolism.. Five selected circulating miRNAs (miR-125a-5p, miR-146a, miR-10a, miR-21 and miR-33a) were individually analyzed by TaqMan miRNA assays along with lipid and inflammation parameters in sera from 20 hyperlipidemic (HL) and/or hyperglycemic (HG) patients, and compared with data from five normolipidemic/normoglycemic subjects.

Article Title: Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire
Article Snippet: Essentially, miRNAs from biofluids such as plasma and serum are highly resistant to freeze thaw, RNAses, room temperature, boiling and pH changes [ , ].

Control:

Article Title: MicroRNAs in biofluids are novel tools for bladder cancer screening
Article Snippet: Currently, there are many methodological pitfalls that need to be addressed in order for miRNAs from biofluids to be used for clinical applications.

Article Title: Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age
Article Snippet: Given the robust stability of miRNAs in plasma, circulating miRNAs have been used as excellent potential biomarkers for complex systemic diseases, and many studies have shown that miRNAs from biofluids can be used as risk markers for cardiovascular complications [11,15].

Article Title: Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera.
Article Snippet: MicroRNAs (miRNAs) are small non-coding RNA sequences that regulate gene expression post-transcriptionally by translation inhibition or mRNA degradation.. The aim of the present study was to analyze serum miRNAs modulated by hyperlipidemia and/or hyperglycemia and to correlate them with biochemical parameters within lipid metabolism.. Five selected circulating miRNAs (miR-125a-5p, miR-146a, miR-10a, miR-21 and miR-33a) were individually analyzed by TaqMan miRNA assays along with lipid and inflammation parameters in sera from 20 hyperlipidemic (HL) and/or hyperglycemic (HG) patients, and compared with data from five normolipidemic/normoglycemic subjects.

Article Title: Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire
Article Snippet: Essentially, miRNAs from biofluids such as plasma and serum are highly resistant to freeze thaw, RNAses, room temperature, boiling and pH changes [ , ].

Clinical Proteomics:

Article Title: MicroRNAs in biofluids are novel tools for bladder cancer screening
Article Snippet: Currently, there are many methodological pitfalls that need to be addressed in order for miRNAs from biofluids to be used for clinical applications.

Article Title: Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age
Article Snippet: Given the robust stability of miRNAs in plasma, circulating miRNAs have been used as excellent potential biomarkers for complex systemic diseases, and many studies have shown that miRNAs from biofluids can be used as risk markers for cardiovascular complications [11,15].

Article Title: Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera.
Article Snippet: MicroRNAs (miRNAs) are small non-coding RNA sequences that regulate gene expression post-transcriptionally by translation inhibition or mRNA degradation.. The aim of the present study was to analyze serum miRNAs modulated by hyperlipidemia and/or hyperglycemia and to correlate them with biochemical parameters within lipid metabolism.. Five selected circulating miRNAs (miR-125a-5p, miR-146a, miR-10a, miR-21 and miR-33a) were individually analyzed by TaqMan miRNA assays along with lipid and inflammation parameters in sera from 20 hyperlipidemic (HL) and/or hyperglycemic (HG) patients, and compared with data from five normolipidemic/normoglycemic subjects.

Article Title: Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire
Article Snippet: Essentially, miRNAs from biofluids such as plasma and serum are highly resistant to freeze thaw, RNAses, room temperature, boiling and pH changes [ , ].

RNA Extraction:

Article Title: MicroRNAs in biofluids are novel tools for bladder cancer screening
Article Snippet: Currently, there are many methodological pitfalls that need to be addressed in order for miRNAs from biofluids to be used for clinical applications.

Article Title: Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age
Article Snippet: Given the robust stability of miRNAs in plasma, circulating miRNAs have been used as excellent potential biomarkers for complex systemic diseases, and many studies have shown that miRNAs from biofluids can be used as risk markers for cardiovascular complications [11,15].

Article Title: Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera.
Article Snippet: MicroRNAs (miRNAs) are small non-coding RNA sequences that regulate gene expression post-transcriptionally by translation inhibition or mRNA degradation.. The aim of the present study was to analyze serum miRNAs modulated by hyperlipidemia and/or hyperglycemia and to correlate them with biochemical parameters within lipid metabolism.. Five selected circulating miRNAs (miR-125a-5p, miR-146a, miR-10a, miR-21 and miR-33a) were individually analyzed by TaqMan miRNA assays along with lipid and inflammation parameters in sera from 20 hyperlipidemic (HL) and/or hyperglycemic (HG) patients, and compared with data from five normolipidemic/normoglycemic subjects.

Article Title: Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire
Article Snippet: Essentially, miRNAs from biofluids such as plasma and serum are highly resistant to freeze thaw, RNAses, room temperature, boiling and pH changes [ , ].

Purification:

Article Title: MicroRNAs in biofluids are novel tools for bladder cancer screening
Article Snippet: Currently, there are many methodological pitfalls that need to be addressed in order for miRNAs from biofluids to be used for clinical applications.

Article Title: Circulating miR-33a and miR-33b are up-regulated in familial hypercholesterolaemia in paediatric age
Article Snippet: Given the robust stability of miRNAs in plasma, circulating miRNAs have been used as excellent potential biomarkers for complex systemic diseases, and many studies have shown that miRNAs from biofluids can be used as risk markers for cardiovascular complications [11,15].

Article Title: Analysis of circulating microRNAs that are specifically increased in hyperlipidemic and/or hyperglycemic sera.
Article Snippet: MicroRNAs (miRNAs) are small non-coding RNA sequences that regulate gene expression post-transcriptionally by translation inhibition or mRNA degradation.. The aim of the present study was to analyze serum miRNAs modulated by hyperlipidemia and/or hyperglycemia and to correlate them with biochemical parameters within lipid metabolism.. Five selected circulating miRNAs (miR-125a-5p, miR-146a, miR-10a, miR-21 and miR-33a) were individually analyzed by TaqMan miRNA assays along with lipid and inflammation parameters in sera from 20 hyperlipidemic (HL) and/or hyperglycemic (HG) patients, and compared with data from five normolipidemic/normoglycemic subjects.

Article Title: Analysis of Biobanked Serum from a Mycobacterium avium subsp paratuberculosis Bovine Infection Model Confirms the Remarkable Stability of Circulating miRNA Profiles and Defines a Bovine Serum miRNA Repertoire
Article Snippet: Essentially, miRNAs from biofluids such as plasma and serum are highly resistant to freeze thaw, RNAses, room temperature, boiling and pH changes [ , ].



Similar Products

90
Biofluids Inc mirna from biofluids
Bioinformatic analysis of key biofluid-derived microRNAs. Top enriched pathways (Fisher exact test p < 0.05) associated with ( a ) most consistent <t>miRNA</t> <t>across</t> <t>biofluids,</t> miR-331-5p ( b ) most reported miRNA, miR-24-3p and miR-214-3p and ( c ) miRNA reported without conflicting direction of change, miR-19b-3p, miR-24-3p, miR-146a-5p, and miR-221-3p and ( d ) Venn Diagram showing the target genes regulated by the key biofluid-derived microRNAs. Overlapping target genes: CCND2 (Cyclin D2), CDK6 (Cyclin Dependent Kinase 6), CDNKN1A (cyclin dependent kinase inhibitor 1A) and MDM2 (Mouse Double Minute 2).
Mirna From Biofluids, supplied by Biofluids Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirnas+from+biofluids/mirnas+in+biofluids/pmc10539377-52-8-10
Average 90 stars, based on 1 article reviews
mirna from biofluids - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Biofluids Inc mirnas from biofluids
Bioinformatic analysis of key biofluid-derived microRNAs. Top enriched pathways (Fisher exact test p < 0.05) associated with ( a ) most consistent <t>miRNA</t> <t>across</t> <t>biofluids,</t> miR-331-5p ( b ) most reported miRNA, miR-24-3p and miR-214-3p and ( c ) miRNA reported without conflicting direction of change, miR-19b-3p, miR-24-3p, miR-146a-5p, and miR-221-3p and ( d ) Venn Diagram showing the target genes regulated by the key biofluid-derived microRNAs. Overlapping target genes: CCND2 (Cyclin D2), CDK6 (Cyclin Dependent Kinase 6), CDNKN1A (cyclin dependent kinase inhibitor 1A) and MDM2 (Mouse Double Minute 2).
Mirnas From Biofluids, supplied by Biofluids Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirnas+from+biofluids/mirnas+in+biofluids/pmc09913542-86-8-10
Average 90 stars, based on 1 article reviews
mirnas from biofluids - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

90
Biofluids Inc exosomal mrnas and mirnas from biofluids samples
Bioinformatic analysis of key biofluid-derived microRNAs. Top enriched pathways (Fisher exact test p < 0.05) associated with ( a ) most consistent <t>miRNA</t> <t>across</t> <t>biofluids,</t> miR-331-5p ( b ) most reported miRNA, miR-24-3p and miR-214-3p and ( c ) miRNA reported without conflicting direction of change, miR-19b-3p, miR-24-3p, miR-146a-5p, and miR-221-3p and ( d ) Venn Diagram showing the target genes regulated by the key biofluid-derived microRNAs. Overlapping target genes: CCND2 (Cyclin D2), CDK6 (Cyclin Dependent Kinase 6), CDNKN1A (cyclin dependent kinase inhibitor 1A) and MDM2 (Mouse Double Minute 2).
Exosomal Mrnas And Mirnas From Biofluids Samples, supplied by Biofluids Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/mirnas+from+biofluids/mirnas+in+biofluids/pm34710587-173-14-14
Average 90 stars, based on 1 article reviews
exosomal mrnas and mirnas from biofluids samples - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Bioinformatic analysis of key biofluid-derived microRNAs. Top enriched pathways (Fisher exact test p < 0.05) associated with ( a ) most consistent miRNA across biofluids, miR-331-5p ( b ) most reported miRNA, miR-24-3p and miR-214-3p and ( c ) miRNA reported without conflicting direction of change, miR-19b-3p, miR-24-3p, miR-146a-5p, and miR-221-3p and ( d ) Venn Diagram showing the target genes regulated by the key biofluid-derived microRNAs. Overlapping target genes: CCND2 (Cyclin D2), CDK6 (Cyclin Dependent Kinase 6), CDNKN1A (cyclin dependent kinase inhibitor 1A) and MDM2 (Mouse Double Minute 2).

Journal: Scientific Reports

Article Title: MicroRNAs in Parkinson’s disease: a systematic review and diagnostic accuracy meta-analysis

doi: 10.1038/s41598-023-43096-9

Figure Lengend Snippet: Bioinformatic analysis of key biofluid-derived microRNAs. Top enriched pathways (Fisher exact test p < 0.05) associated with ( a ) most consistent miRNA across biofluids, miR-331-5p ( b ) most reported miRNA, miR-24-3p and miR-214-3p and ( c ) miRNA reported without conflicting direction of change, miR-19b-3p, miR-24-3p, miR-146a-5p, and miR-221-3p and ( d ) Venn Diagram showing the target genes regulated by the key biofluid-derived microRNAs. Overlapping target genes: CCND2 (Cyclin D2), CDK6 (Cyclin Dependent Kinase 6), CDNKN1A (cyclin dependent kinase inhibitor 1A) and MDM2 (Mouse Double Minute 2).

Article Snippet: Using meta-analysis, we evaluated the diagnostic utility of miRNA from biofluids capable of discriminating between PD patients and controls.

Techniques: Derivative Assay